Impact of Frailty on the Benefits of Dual Pathway Inhibition for the Secondary Prevention of Cardiovascular Events in the COMPASS Randomised Trial.

Leong, Darryl P; Bosch, Jackie; Bhatt, Deepak L; Avezum, Alvaro; Yuan, Fei; Yusuf, Salim; Eikelboom, John W.

Afiliação

Leong DP; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada. Electronic address: darryl.leong@phri.ca.
Bosch J; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada; Department of Rehabilitation Sciences, McMaster University, Hamilton, Canada.
Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Avezum A; International Research Center, Hospital Alemão Oswaldo Cruz, São Paolo, São Paolo, Brazil.
Yuan F; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada.
Yusuf S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada.
Eikelboom JW; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Canada; Department of Medicine, McMaster University, Hamilton, Canada.

Can J Cardiol ; 2024 Jun 22.

Article em En | MEDLINE | ID: mdl-38914270

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article